Val-Cit-PABC-DOX
Product Specifications
CAS Number
1022094-34-3
Target
Drug-Linker Conjugates for ADC, Topoisomerase
Related Pathways
Antibody-drug Conjugate/ADC Related, DNA Damage/DNA Repair
Bioactivity
Val-Cit-PABC-DOX (compound 10109), a conjugate based on epsilon-poly-L-lysine, functions as an agent-linker for ADC, employing Doxorubicin—an inhibitor of both DNA topoisomerase I and II—as the linked agent via the Val-Cit-PABC linker.
Smiles
OC=1C2=C([C@@H](O[C@H]3C[C@H](NC(OCC4=CC=C(NC([C@@H](NC([C@H](C(C)C)N)=O)CCCNC(N)=O)=O)C=C4)=O)[C@H](O)[C@H](C)O3)C[C@@](C(CO)=O)(O)C2)C(O)=C5C1C(=O)C=6C(C5=O)=C(OC)C=CC6
Molecular Formula
C46H56N6O16
Molecular Weight
948.97
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15325025 1 Vial
Lentiviral human HMGB4 shRNA (UAS) - Lentiviral human HMGB4 shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details ST804 40 Cases / 80 Cores
Stomach adenocarcinoma and normal tissue array, including pathology grade, TNM and clinical satge, 40 cases/80 cores, no overlaps with BC01012 or ST801
Sign In for Pricing
View Details